This column summarizes New Drug Applications (NDAs) approved in the
fourth quarter 2015 (November-December 2015). In these two months,
FDA approved 30 NDAs.
Twenty-five (65.8%) NDAs were for small molecules while the remaining
13 (34.2%) were for large molecules. Most of the large molecules were
used in the cancer therapy. In this quarter, 18 companies (47.4%)
receiving NDA approvals were large ...
This column summarizes New Drug Applications (NDAs) from May 2015
to July 2015. In this quarter, FDA approved 26 NDAs.
Monday, November 30, 2015
This column summarizes New Drug Applications (NDAs) for March and
April 2015. In these two months, FDA approved 25 NDAs.